Biotech Values

[dewophile]

I suggested in my post that the commercial opportunity may be larger than predicted bc there may be more reason to treat covid early even in low risk settings if you think it might lower the risk for long haul sequelae. The antivaxers along w the emerging variants probably means we will have covid to some degree for a long time